Interv Akut Kardiol. 2013;12(4):171-172

Má transapikální implantace aortální chlopně budoucnost?

Jan Vojáček, Jan Harrer
Kardiochirurgická klinika LF Hradec Králové, Univerzita Karlova v Praze
Kardiocentrum FN Hradec Králové

Published: December 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vojáček J, Harrer J. Má transapikální implantace aortální chlopně budoucnost? Interv Akut Kardiol. 2013;12(4):171-172.
Download citation

References

  1. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002; 106(24): 3006-3008. Go to original source... Go to PubMed...
  2. Webb JG, Chandavimol M, Thompson CR, et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation. 2006; 113(6): 842-850. Go to original source... Go to PubMed...
  3. Ye J, Cheung A, Lichtenstein SV, et al. Transapical aortic valve implantation in humans. J Thorac Cardiovasc Surg. 2006; 131(5): 1194-1196. Go to original source... Go to PubMed...
  4. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003; 24(13): 1231-1243. Go to original source... Go to PubMed...
  5. Smith CR, Leon MB, Mack MJ, et al. PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011; 364(23): 2187-2198. Go to original source... Go to PubMed...
  6. Smith CR, Leon MB, Mack MJ, et al. PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011; 364(23): 2187-2198. Go to original source... Go to PubMed...
  7. Kodali SK, Williams MR, Smith CR, et al. PARTNER Trial Investigators.Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012; 366(18): 1686-1695. Go to original source... Go to PubMed...
  8. Thomas M, Schymik G, Walther T, et al. Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2010; 122(1): 62-69. Go to original source... Go to PubMed...
  9. Rodés-Cabau J, Webb JG, Cheung A, Ye J, et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol. 2010; 55(11): 1080-1090. Go to original source... Go to PubMed...
  10. Walther T, Thielmann M, Kempfert J, et al. One-year multicentre outcomes of transapical aortic valve implantation using the SAPIEN XT(TM) valve: the PREVAIL transapical study. Eur J Cardiothorac Surg. 2013; 43(5): 986-992. Go to original source... Go to PubMed...
  11. Harrer J, Vojáček J, ©»ásek J, et al. První zkuąenosti s transapikální implantací chlopně u nemocných s aortální stenózou. Interv Akut Kardiol 2009; 8(2): 100-104.
  12. J. ©»ásek. Výsledky TAVI v ČR. Porovnání se světem. XXI. Výroční sjezd České Kardiologické společnosti.
  13. Funkat AK, Beckmann A, Lewandowski J, Frie M, et al. Cardiac surgery in Germany during 2011: a report on behalf of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg. 2012; 60(6): 371-382. Go to original source... Go to PubMed...
  14. Gummert JF, Funkat AK, Beckmann A, et al. Cardiac surgery in Germany during 2010: a report on behalf of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg. 2011; 59(5): 259-267. Go to original source... Go to PubMed...
  15. Gummert JF, Funkat A, Beckmann A, et al. Cardiac surgery in Germany during 2009. A report on behalf of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg. 2010; 58(7): 379-386. Go to original source... Go to PubMed...




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.